483
Bioreliance Ltd.Bioreliance Ltd. – FDA 483, Sep 27, 2019
Record Details
An FDA inspection of Bioreliance Ltd. in Glasgow, United Kingdom, a manufacturer of API starting material and control testing laboratory, revealed three significant observations. These included failures to follow written sanitation procedures for equipment cleaning, deficiencies in aseptic simulations for operator qualification, and a lack of quality unit review for equipment changes or repairs during on-demand maintenance.
View Company Profile
ID · ad0ac3f7-301c-407d-b274-68e2753f4c99
Other documents for Bioreliance Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.